The reconstituted solution remains stable for approximately 4 weeks under proper refrigeration
Theo mt nghin cu, mi ngy bn cn tiu th ti thiu 250 mg tng lng EPA v DHA p ng nhu cu ca c th
In the U.K., Mounjaro is not yet recommended due to lack of sufficient evidence on efficacy and cost-effectiveness
So far, studies have reported: Phase 2 (48 weeks): up to 24.2% average weight loss Phase 3 TRIUMPH-4 topline (68 weeks): 28.7% average weight loss (press release) What that looks like: If you start at 100 kg : 24.2% 24 kg average loss 28.7% 29 kg average loss Side effects and safety signals (what we know so far) Phase 2 (peer-reviewed) In the phase 2 trial, the most common adverse events were gastrointestinal and dose-related, typically mild to moderate
This product is not intended for human or animal use, consumption, injection, topical application, therapeutic purposes, or diagnostic procedures